Olympus Scope Adverse Events in South Carolina — What FDA Reports Reveal

Super Lawyers® 2014–2024CALL 24/7(888) 348-2735

Olympus Scope — Infection Claims

Hospitalized With an Infection After a Scope Procedure?

If you were told it was “just a complication,” Olympus’s federal guilty plea — and $85 million in penalties — tell a different story. In two minutes, you can know whether your case qualifies.

ACTIVE LITIGATION. 250+ patients · most recent filing: June 2026 · deadlines vary by state — some as short as one year.

Were you hospitalized with an infection within 30 days of an endoscopy or scope procedure?

Yes — See If My Case Qualifiesfree · takes 2 minutes
I think so / not sure

Free · confidential · no fee unless there is a recovery · answering doesn’t commit you to anything. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney’s fee is a percentage of the gross recovery, calculated before expenses are deducted.

Prefer to talk it through? (888) 348-2735 — free and confidential.

Stefanie A. Murphy & Matthew T. Marin

Partners

You’ll get a straight answer even if it’s “you don’t qualify.” Everything you share is confidential — even if you never hire us. No fee unless there is a recovery; costs are advanced and reimbursed only out of a recovery. If you do qualify, our Olympus scope litigation team requests the medical and hospital records — you don’t chase them.

Qualification depends on what the medical records show — the scope involved, the infection, and the timing. We’ll review them and give you a straight answer either way.

Matthew T. Marin, J.D. — Admitted in Rhode Island, South Carolina, Connecticut, and Massachusetts.Stefanie A. Murphy, J.D. — Admitted in Rhode Island, Connecticut, and Massachusetts.The FDA MAUDE database contains adverse event reports from South Carolina healthcare facilities linked to Olympus devices. Marin & Murphy — SC-licensed, Charleston office — analyzes this data to identify and assist South Carolina patients with potential claims.

Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney’s fee is a percentage of the gross recovery, calculated before expenses are deducted.

What Is the FDA MAUDE Database and Why Does It Matter for SC Patients?

The FDA Manufacturer and User Facility Device Experience (MAUDE) database is a publicly accessible repository of adverse event reports submitted to the FDA by medical device manufacturers, importers, and healthcare facilities. Federal law requires that user facilities — including hospitals and ambulatory surgical centers — report device-related patient deaths to the FDA and the manufacturer, and report device-related serious injuries to the manufacturer.

Manufacturers must then report these events to the FDA. For Olympus scope litigation, the MAUDE database is a critical evidentiary resource. It contains adverse event reports identifying specific Olympus device model numbers (including TJF-Q180V, TJF-160VR, TJF-160R, and related duodenoscope models), event descriptions, patient outcomes, and in many cases the reporting facility. These reports can corroborate patient claims, identify clusters of adverse events at particular facilities, and establish Olympus’s notice of the contamination problem over time.

South Carolina healthcare facilities that perform ERCP and other endoscopic procedures are subject to these federal reporting obligations. MAUDE reports from South Carolina facilities involving Olympus devices may be directly relevant to SC patients’ claims and are reviewed by Marin & Murphy as part of the case evaluation process.

What MAUDE Reports Reveal About Olympus Scopes in South Carolina

The MAUDE database contains thousands of adverse event reports nationwide linked to Olympus endoscopes over a multi-decade period. Analysis of these reports reveals a consistent pattern: contamination events, infection transmission, device contamination after reprocessing, and inadequate cleaning mechanism design — all recurring across Olympus scope model lines. For South Carolina specifically, the MAUDE database contains adverse-event reports that carry South Carolina reporter coding for Olympus duodenoscopes.

Because MAUDE de-identifies the reporting user facility, these South Carolina–coded reports do not name the specific hospital or health system involved — no individual South Carolina facility can be identified from the reports themselves. South Carolina is served by major academic and community health systems that perform ERCP and other endoscopic procedures, but the MAUDE records do not attribute any event to a named facility, and this page does not associate any specific South Carolina hospital with an adverse event.

Marin & Murphy reviews MAUDE data as part of its SC patient intake process. If you underwent a scope procedure at any South Carolina healthcare facility and subsequently developed an infection, our team will review the available MAUDE reports and other primary records as part of your case evaluation.

FDA MAUDE Data: South Carolina-Coded Olympus Duodenoscope Reports

As of July 4, 2026, the FDA MAUDE adverse event database contains 65 adverse event reports carrying South Carolina reporter coding for Olympus duodenoscopes (device model prefix “TJF”). Of these 65 South Carolina–coded reports, 53 are classified as device malfunctions and 11 as injuries, with 0 South Carolina–coded deaths. MAUDE reports are voluntary and unverified, may be incomplete or duplicative, and do not establish that an Olympus device caused any reported event; the figures represent reports, not confirmed injuries..

How Marin & Murphy Uses MAUDE Data for SC Patients

Matthew T. Marin, J.D. is admitted in South Carolina. Stefanie A. Murphy, J.D. is admitted in Rhode Island, Connecticut, and Massachusetts. The firm operates a Charleston office at 997 Morrison Dr Ste 200, Charleston SC 29403, phone (843) 642-2449. South Carolina is not a referral state for Marin & Murphy — it is a licensed home practice state. South Carolina patients receive direct representation from attorneys admitted to the South Carolina bar who practice in the state.

When evaluating a South Carolina claim, this firm reviews the MAUDE adverse-event reports that carry South Carolina reporter coding for Olympus duodenoscopes. Because MAUDE de-identifies the reporting user facility, these reports do not name the hospital or health system involved, and this firm does not associate any specific South Carolina facility with an adverse event. When a South Carolina patient contacts Marin & Murphy for an evaluation, we:

1. Review available MAUDE adverse event reports from the patient’s facility involving Olympus device model numbers
2. Request procedure records identifying the specific Olympus device used and the lot/serial number
3. Cross-reference the procedure date against known Olympus contamination alerts, recalls, and field safety notices
4. Assess the patient’s infection diagnosis, treatment records, and documented outcomes
5. Evaluate the statute of limitations status under S.C. Code Ann. § 15-3-530 (3-year personal injury SOL)

South Carolina’s Statute of Limitations for Olympus Scope Claims

South Carolina’s statute of limitations for personal injury is 3 years from the date of injury or discovery under S.C. Code Ann. § 15-3-530. The SOL floor in Marin & Murphy’s intake protocol requires 90 days minimum remaining at intake (60-day workup + 30-day buffer). Contact Marin & Murphy promptly. Even if you believe your filing deadline may have passed, contact us before assuming you have no options — depending on the circumstances, there may still be options worth exploring.

For wrongful death claims, South Carolina’s wrongful death statute (S.C. Code Ann. § 15-51-10 et seq.) applies. The statute of limitations for wrongful death claims is also 3 years running from the date of the death. The decedent’s estate or surviving family members may pursue both wrongful death and survival action claims.

Signs a South Carolina Patient May Qualify

South Carolina patients should contact Marin & Murphy if they experienced all of the following:

• An endoscopic procedure — including ERCP, upper endoscopy, colonoscopy, or bronchoscopy — at any South Carolina hospital or surgical center, at any time in the past 3 years (or earlier if the infection was only recently linked to the procedure)
• A bacterial infection diagnosed within 30–90 days of the procedure, including CRE, MDRO, sepsis, cholangitis, biliary infection, or other device-associated infection
• Medical documentation connecting the infection to the healthcare setting (hospital infection control report, culture results, or treating physician’s records)

Additional factors that strengthen SC claims:

• Post-procedure infection requiring hospitalization, ICU care, or prolonged antibiotic treatment
• A family member who died following a scope-related infection in South Carolina
• Documentation from the SC facility identifying an infection control investigation
• Procedure records confirming an Olympus TJF-Q180V, TJF-160VR, or similar Olympus duodenoscope
• South Carolina’s 3-year SOL — SOL floor at intake: 90 days minimum remaining

Frequently Asked Questions — SC MAUDE Adverse Events & Olympus Scope Claims

Related Olympus Scope Resources for SC Patients

• South Carolina Olympus scope lawsuit — SC patient rights, direct intake, 3-year SOL.
• ERCP infection lawsuit — how bile duct procedures create contamination risk.
• CRE infection lawsuit — carbapenem-resistant infections from scope procedures.
• Sepsis after endoscopy — signs, symptoms, and legal options.
• National MAUDE adverse event analysis — national scope of Olympus MAUDE data.
• Current Olympus litigation updates — MDL formation, settlement status.